Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1097
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04633447 | A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis | ||
| NCT01866007 | A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants | ||
| NCT05757973 | Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple Myeloma | ||
| NCT03593954 | A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Participants | ||
| NCT02737605 | A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants | ||
| NCT03795402 | Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling | ||
| NCT03109002 | An Epidemiology Study of Treatment Resistant Depression in the United States (US) | ||
| NCT00488631 | An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT02462473 | A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry | ||
| NCT05161598 | Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957) | ||
| NCT01962532 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma | ||
| NCT02260700 | A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants | ||
| NCT02877134 | Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT02141971 | Down Syndrome Biomarker Initiative (DSBI) | ||
| NCT01820936 | A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765 | ||
| NCT03923010 | A Study of Itraconazole in the Management of Superficial Fungal Infections in India | ||
| NCT02397382 | Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis | ||
| NCT02623491 | Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Participants | ||
| NCT02280018 | A Safety, Tolerability and Pharmacokinetics Study of a Single Intravenous Dose of JNJ-49122944 in Healthy Male Participants | ||
| NCT05252520 | A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants | ||
| NCT07082920 | A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer | ||
| NCT04087759 | A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult Participants | ||
| NCT02782104 | A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression | ||
| NCT03270579 | A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070 | ||
| NCT01381848 | A Study of Doripenem in Infants Less Than 12 Weeks of Age | ||
| NCT04821323 | A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix | ||
| NCT06768489 | A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma | ||
| NCT07225946 | A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT01273389 | An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis | ||
| NCT01508182 | A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy Volunteers | ||
| NCT05957276 | Global Patient Registry of Inherited Retinal Diseases | ||
| NCT02381080 | Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy | ||
| NCT02876718 | Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study | ||
| NCT03550950 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy Participants | ||
| NCT04552197 | A Study of JNJ-64251330 in Healthy Participants | ||
| NCT03047317 | A Pharmacokinetic Study of MABp1 in Healthy Volunteers | ||
| NCT01862224 | A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy | ||
| NCT02691520 | Epidemiology of Treatment Resistant Depression in Taiwan | ||
| NCT03693391 | A Study to Investigate Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA Gamma 8) Receptor Occupancy of JNJ-64140284 With Newly Developed Transmembrane AMPA Receptor Regulatory Protein (TARP)-Gamma 8 Positron Emission Tomography (PET) [18F]JNJ-64511070 in Healthy Men | ||
| NCT01974440 | A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma | ||
| NCT05503550 | Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma | ||
| NCT06278051 | An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism | ||
| NCT02367027 | Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions | ||
| NCT04553042 | A Study of Seltorexant in Healthy Participants | ||
| NCT00338286 | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy | ||
| NCT05653427 | A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma | ||
| NCT02228239 | Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants | ||
| NCT02857777 | Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects | ||
| NCT03314181 | A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT03746301 | Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation |
